These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 20019606)
1. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Cederholm T; Palmblad J Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):150-5. PubMed ID: 20019606 [TBL] [Abstract][Full Text] [Related]
2. ω-3 fatty acids in the prevention of cognitive decline in humans. Cederholm T; Salem N; Palmblad J Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198 [TBL] [Abstract][Full Text] [Related]
3. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease--but how and why? Das UN Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):11-9. PubMed ID: 18054217 [TBL] [Abstract][Full Text] [Related]
4. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Kidd PM Altern Med Rev; 2007 Sep; 12(3):207-27. PubMed ID: 18072818 [TBL] [Abstract][Full Text] [Related]
6. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study. Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954 [TBL] [Abstract][Full Text] [Related]
7. Fish, docosahexaenoic acid and Alzheimer's disease. Cunnane SC; Plourde M; Pifferi F; Bégin M; Féart C; Barberger-Gateau P Prog Lipid Res; 2009 Sep; 48(5):239-56. PubMed ID: 19362576 [TBL] [Abstract][Full Text] [Related]
8. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756 [TBL] [Abstract][Full Text] [Related]
9. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585 [TBL] [Abstract][Full Text] [Related]
10. Dietary omega-3 fatty acids for women. Bourre JM Biomed Pharmacother; 2007; 61(2-3):105-12. PubMed ID: 17254747 [TBL] [Abstract][Full Text] [Related]
11. Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish. Pauwels EK; Volterrani D; Mariani G; Kairemo K Drug News Perspect; 2009 May; 22(4):205-13. PubMed ID: 19536365 [TBL] [Abstract][Full Text] [Related]
12. Diet and Alzheimer's disease risk factors or prevention: the current evidence. Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488 [TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study. Irving GF; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Brismar K; Hjorth E; Palmblad J; Vessby B; Vedin I; Wahlund LO; Cederholm T J Am Geriatr Soc; 2009 Jan; 57(1):11-7. PubMed ID: 19054188 [TBL] [Abstract][Full Text] [Related]
14. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial. Phillips MA; Childs CE; Calder PC; Rogers PJ Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267 [TBL] [Abstract][Full Text] [Related]
16. Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease. Plourde M; Fortier M; Vandal M; Tremblay-Mercier J; Freemantle E; Bégin M; Pifferi F; Cunnane SC Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):301-8. PubMed ID: 18036804 [TBL] [Abstract][Full Text] [Related]
17. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy. Pauwels EK; Kostkiewicz M Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636 [TBL] [Abstract][Full Text] [Related]
18. Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults - any news? Cederholm T Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):104-109. PubMed ID: 27977429 [TBL] [Abstract][Full Text] [Related]
19. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. Lavie CJ; Milani RV; Mehra MR; Ventura HO J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687 [TBL] [Abstract][Full Text] [Related]
20. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids. Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]